Back to
ALPS ADVISORS INC
INBX
Showing 2 of 3 quarters
Position history for
ALPS ADVISORS INC's holdings in INHIBRX BIOSCIENCES INC
No. ALPS Advisors exited its INBX (Inhibrx Biosciences) position in Q4 2024. Its Q3 2024 13F listed 10,952 shares worth $171,508. ALPS Advisors already held INBX in its Q2 2024 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$171,508
Total Shares Change
-10,952
Quarter-by-Quarter History